My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 190

    1.

    Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.

    DudokdeWit AC, Tibben A, Duivenvoorden HJ, Frets PG, Zoeteweij MW, Losekoot M, van Haeringen A, Niermeijer MF, Passchier J.

    J Med Genet. 1997 May;34(5):382-90.PMID: 9152835 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.

    DudokdeWit AC, Tibben A, Duivenvoorden HJ, Niermeijer MF, Passchier J, Trijsburg RW.

    Am J Med Genet. 1998 Jan 6;75(1):62-74. Review.PMID: 9450860 [PubMed - indexed for MEDLINE]Related articles

    3.

    Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

    DudokdeWit AC, Tibben A, Duivenvoorden HJ, Niermeijer MF, Passchier J.

    J Med Genet. 1998 Sep;35(9):745-54.PMID: 9733033 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup.

    Dudok deWit AC, Duivenvoorden HJ, Passchier J, Niermeijer MF, Tibben A.

    Psychosom Med. 1998 Sep-Oct;60(5):543-9.PMID: 9773756 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.

    Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman JJ, Cloostermans T, Demyttenaere K, Dom R, Fryns JP.

    J Med Genet. 1999 Dec;36(12):897-905.PMID: 10593997 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

    Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

    Eur J Hum Genet. 2001 Jul;9(7):492-500.PMID: 11464240 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

    Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

    J Med Genet. 1999 Dec;36(12):906-13.PMID: 10593998 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.

    Tibben A, Duivenvoorden HJ, Niermeijer MF, Vegter-van der Vlis M, Roos RA, Verhage F.

    Psychosom Med. 1994 Nov-Dec;56(6):526-32.PMID: 7871108 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Psychological distress in the 5-year period after predictive testing for Huntington's disease.

    Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R, Fryns JP.

    Eur J Hum Genet. 2003 Jan;11(1):30-8.PMID: 12529703 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

    Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF.

    Am J Med Genet A. 2003 Jun 15;119A(3):266-72.PMID: 12784290 [PubMed - indexed for MEDLINE]Related articles

    11.

    "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).

    Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB.

    Am J Med Genet C Semin Med Genet. 2008 Feb 15;148C(1):47-55.PMID: 18189288 [PubMed - indexed for MEDLINE]Related articles

    12.

    Psychological consequences of predictive genetic testing: a systematic review.

    Broadstock M, Michie S, Marteau T.

    Eur J Hum Genet. 2000 Oct;8(10):731-8. Review.PMID: 11039571 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.

    Tibben A, Timman R, Bannink EC, Duivenvoorden HJ.

    Health Psychol. 1997 Jan;16(1):20-35.PMID: 9028813 [PubMed - indexed for MEDLINE]Related articles

    14.

    United Kingdom experience with presymptomatic testing of individuals at 25% risk for Huntington's disease.

    Benjamin CM, Lashwood A.

    Clin Genet. 2000 Jul;58(1):41-9.PMID: 10945660 [PubMed - indexed for MEDLINE]Related articles

    15.

    Psychological impact of receiving a BRCA1/BRCA2 test result.

    Lodder L, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, van den Ouweland AM, Niermeijer MF.

    Am J Med Genet. 2001 Jan 1;98(1):15-24.PMID: 11426450 [PubMed - indexed for MEDLINE]Related articles

    16.

    Exploration of the effects of predictive testing for Huntington disease on intimate relationships.

    Quaid KA, Wesson MK.

    Am J Med Genet. 1995 May 22;57(1):46-51.PMID: 7645597 [PubMed - indexed for MEDLINE]Related articles

    17.

    Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.

    Adam S, Wiggins S, Whyte P, Bloch M, Shokeir MH, Soltan H, Meschino W, Summers A, Suchowersky O, Welch JP, et al.

    J Med Genet. 1993 Jul;30(7):549-56.PMID: 8411026 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.

    Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman JJ, Cloostermans T, Demyttenaere K, Dom R, Fryns JP, Van den Berghe H.

    J Med Genet. 1996 Sep;33(9):737-43.PMID: 8880572 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Predictive testing for Huntington's disease: relationship with partners after testing.

    Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R, Fryns JP.

    Clin Genet. 2004 Jan;65(1):24-31.PMID: 15032971 [PubMed - indexed for MEDLINE]Related articles

    20.

    One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

    Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C, van Geel AN, Tilanus MM, Bartels CC, Verhoog LC, Brekelmans CT, Burger CW, Niermeijer MF.

    Breast Cancer Res Treat. 2002 May;73(2):97-112.PMID: 12088120 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity